OTC Benadryl in UK?
This article was originally published in The Tan Sheet
Executive Summary
Reclassification of Benadryl Allergy Relief in the UK from behind-the-counter "Pharmacy" status to over-the-counter "General Sale" status would allow "more choice for individuals in how they treat this self-limiting condition," Pfizer Consumer Healthcare says in Nov. 17 submission to the Medicines & Healthcare products Regulatory Agency. Non-sedating antihistamines such as loratadine already "are well-established in the general sale category," the consultation document notes, adding that allergies can be "easily" treated "without the intervention of a pharmacist"...
You may also be interested in...
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests
The rulemaking is supposed to formalize the Patent Trial and Appeal Board process, which has been in an interim status since a Supreme Court decision, giving manufacturers more ability to request oversight of the decisions.